proadifen has been researched along with Ovarian Neoplasms in 1 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Proadifen (SKF-525A) is a P450 monooxygenase inhibitor with potential anti-proliferative activity and the ability to potentiate the toxicity of hypericin-mediated photodynamic therapy and mitoxantrone via alteration of ABC transport proteins." | 1.43 | Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin. ( Fedoročko, P; Hiľovská, L; Jendželovská, Z; Jendželovský, R; Kovaľ, J; Mikeš, J, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jendželovský, R | 1 |
| Jendželovská, Z | 1 |
| Hiľovská, L | 1 |
| Kovaľ, J | 1 |
| Mikeš, J | 1 |
| Fedoročko, P | 1 |
1 other study available for proadifen and Ovarian Neoplasms
| Article | Year |
|---|---|
Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin.
Topics: Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Carcinoma, Ovarian Epithelial; Cell Line, Tumo | 2016 |